430 related articles for article (PubMed ID: 11014195)
1. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
Allen TM; O'Connor DH; Jing P; Dzuris JL; Mothé BR; Vogel TU; Dunphy E; Liebl ME; Emerson C; Wilson N; Kunstman KJ; Wang X; Allison DB; Hughes AL; Desrosiers RC; Altman JD; Wolinsky SM; Sette A; Watkins DI
Nature; 2000 Sep; 407(6802):386-90. PubMed ID: 11014195
[TBL] [Abstract][Full Text] [Related]
2. Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques.
Mason RD; De Rose R; Kent SJ
Virology; 2009 Jun; 388(2):315-23. PubMed ID: 19394064
[TBL] [Abstract][Full Text] [Related]
3. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
O'Connor DH; Allen TM; Vogel TU; Jing P; DeSouza IP; Dodds E; Dunphy EJ; Melsaether C; Mothé B; Yamamoto H; Horton H; Wilson N; Hughes AL; Watkins DI
Nat Med; 2002 May; 8(5):493-9. PubMed ID: 11984594
[TBL] [Abstract][Full Text] [Related]
4. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T
J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550
[TBL] [Abstract][Full Text] [Related]
5. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
[TBL] [Abstract][Full Text] [Related]
6. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
7. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
[TBL] [Abstract][Full Text] [Related]
8. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
Barouch DH; Powers J; Truitt DM; Kishko MG; Arthur JC; Peyerl FW; Kuroda MJ; Gorgone DA; Lifton MA; Lord CI; Hirsch VM; Montefiori DC; Carville A; Mansfield KG; Kunstman KJ; Wolinsky SM; Letvin NL
Nat Immunol; 2005 Mar; 6(3):247-52. PubMed ID: 15685174
[TBL] [Abstract][Full Text] [Related]
9. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.
Evans DT; O'Connor DH; Jing P; Dzuris JL; Sidney J; da Silva J; Allen TM; Horton H; Venham JE; Rudersdorf RA; Vogel T; Pauza CD; Bontrop RE; DeMars R; Sette A; Hughes AL; Watkins DI
Nat Med; 1999 Nov; 5(11):1270-6. PubMed ID: 10545993
[TBL] [Abstract][Full Text] [Related]
10. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
[TBL] [Abstract][Full Text] [Related]
11. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
[TBL] [Abstract][Full Text] [Related]
12. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.
Maggiorella MT; Baroncelli S; Michelini Z; Fanales-Belasio E; Moretti S; Sernicola L; Cara A; Negri DR; Buttò S; Fiorelli V; Tripiciano A; Scoglio A; Caputo A; Borsetti A; Ridolfi B; Bona R; ten Haaft P; Macchia I; Leone P; Pavone-Cossut MR; Nappi F; Ciccozzi M; Heeney J; Titti F; Cafaro A; Ensoli B
Vaccine; 2004 Sep; 22(25-26):3258-69. PubMed ID: 15308348
[TBL] [Abstract][Full Text] [Related]
13. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI
J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723
[TBL] [Abstract][Full Text] [Related]
14. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
[TBL] [Abstract][Full Text] [Related]
15. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
[TBL] [Abstract][Full Text] [Related]
17. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques.
Loh L; Batten CJ; Petravic J; Davenport MP; Kent SJ
J Virol; 2007 May; 81(10):5418-22. PubMed ID: 17344299
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV adaptive immunity: determinants for viral persistence.
Yamamoto H; Matano T
Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
[TBL] [Abstract][Full Text] [Related]
19. Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.
Gooneratne SL; Alinejad-Rokny H; Ebrahimi D; Bohn PS; Wiseman RW; O'Connor DH; Davenport MP; Kent SJ
J Virol; 2014 Dec; 88(24):14310-25. PubMed ID: 25275134
[TBL] [Abstract][Full Text] [Related]
20. An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection.
Smith SM; Pentlicky S; Klase Z; Singh M; Neuveut C; Lu CY; Reitz MS; Yarchoan R; Marx PA; Jeang KT
J Biol Chem; 2003 Nov; 278(45):44816-25. PubMed ID: 12947089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
